Cargando…
A series of patients with minimal change nephropathy treated with rituximab during adolescence and adulthood
BACKGROUND: The treatment of immune suppression dependent minimal change nephropathy (MCN) can be challenging and frequently leads to serious complications. In paediatric patients, successful treatment with rituximab is described in steroid-dependent MCN. There is limited information about the poten...
Autores principales: | Dekkers, Marinus J, Groothoff, Jaap W, Zietse, Robert, Betjes, Michiel G H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4482035/ https://www.ncbi.nlm.nih.gov/pubmed/26112053 http://dx.doi.org/10.1186/s13104-015-1255-0 |
Ejemplares similares
-
Neutralizing Anti-Rituximab Antibodies and Relapse in Membranous Nephropathy Treated With Rituximab
por: Boyer-Suavet, Sonia, et al.
Publicado: (2020) -
Two cases of idiopathic membranous nephropathy treated with rituximab
por: Young Yoon, Jae, et al.
Publicado: (2013) -
Rituximab in Membranous Nephropathy
por: Gauckler, Philipp, et al.
Publicado: (2021) -
Long-Term Sequelae of Severe Acute Kidney Injury in the Critically Ill Patient without Comorbidity: A Retrospective Cohort Study
por: Fortrie, Gijs, et al.
Publicado: (2015) -
COVİD-19 infection in a membranous nephropathy patient treated with rituximab
por: Elcioglu, Omer Celal, et al.
Publicado: (2020)